Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates sorted by
relevance

Admin25.08.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates

29010
Admin03.08.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth

6400
Admin11.08.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth

8102
Admin09.10.2021

The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is

8501
Admin27.08.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth

7401
Admin18.09.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth

Admin13.07.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth

45010
Admin25.08.2021

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth

2101
Admin18.09.2021

Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and

7906
Admin21.08.2021

Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and

9308
Admin29.08.2021

THAL SNS 032 (CAS 2139287-33-3): R&D Systems

7600
Admin13.09.2021

The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via

8708
Admin04.10.2021

The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via

403
Admin28.07.2021

Effect of CYC202 on the induction of apoptosis in MCL. Apopotosis was | Download Scientific

1501
Admin20.08.2021

Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and

8401
Admin17.07.2021

Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS

6305
Admin25.07.2021

UCN-01 | inhibitor of Akt, protein kinase C, PDK1 and cyclin-dependent kinases | Cas# 112953-11

1504
Admin08.08.2021

美国APExBIO中文官网 - SNS-032 (BMS-387032)|CDK inhibitor|CAS# 345627-80-7

2006
Admin27.09.2021

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic

9000
Admin22.08.2021

(PDF) Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9

7403
Admin19.09.2021

Cdk2 inhibitor SNS-032, but not Cdk1 inhibitor JNJ-7706621 selectively | Download Scientific

8301